John H Beigel

28PUBLICATIONS
110CO-AUTHORS
NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAnimal protection (incl. pests and pathogens)Venereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Mar 13, 2026
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial.

Aurélie Ploquin, Rosemarie D Mason, LaSonji A Holman

|Oct 16, 2025
Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza.

John H Beigel, David Oldach

|Apr 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar, Kirsten E Lyke, Christine M Posavad

|Jul 16, 2024
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus.

Surender Khurana, Lisa R King, Jody Manischewitz

|Apr 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.

Kanal Singh, Kevin Rubenstein, Viviane Callier

|Aug 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Angela R Branche, Nadine G Rouphael, David J Diemert

Pageof 5

Frequent Collaborators

7 joint publications

Evan J Anderson

7 joint publications

Lisa Jackson

6 joint publications

Nicole Doria-Rose

5 joint publications

Robert L Atmar